A Commercial Court in Noida has passed an ad interim order in favour of Jubilant Generics Limited, a global pharmaceutical company engaged in manufacture, sale and distribution of prescription and OTC pharmaceutical products with global presence in more than 50 countries, inter alia, restraining 4 defendant Indian entities involved in the manufacture, distribution and export of certain pharmaceutical products viz. Losartan, Citalopram and Amlodipine, using, without authorisation, proprietary technology, confidential trade secrets, and original copyright product dossiers of Jubilant.
The infringing defendants are Medreich Limited, V S International Private Limited, Gracure Pharmaceuticals Limited and Jamp India Pharmaceuticals Private Limited, a subsidiary of Jamp Pharma Corporation, Canada, which were either directly manufacturing and supply/exporting to JAMP Canada these pharmaceutical products, or facilitating such illegal activities. The petitioner has advised the Indian Customs to stop all export of these products on immediate basis.
 (1)_20241122153242_original_image_7.webp)
